Emerging markets & emerging needs: Developing countries vaccine manufacturers' perspective & its current status

Biologicals

Volumn 37, Issue 3, 2009, Pages 165-168

  Jadhav, Suresh S ^a   Gautam, Manish ^a   Gairola, Sunil ^a  

^a Serum Institute of India Ltd   (India)

Author keywords

DCVM; DCVMN; Developing countries; GAVI; Vaccine supply; WHO

Indexed keywords

BCG VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; MEASLES MUMPS RUBELLA VACCINE; ORAL POLIOMYELITIS VACCINE; PNEUMOCOCCUS VACCINE; RABIES VACCINE; TETANUS TOXOID; TYPHOID VACCINE;

ARTICLE; DEVELOPING COUNTRY; DEVELOPING COUNTRY VACCINE MANUFACTURERS' NETWORK; DRUG MARKETING; GOVERNMENT; HEALTH CARE NEED; HEALTH PROGRAM; INTERNATIONAL COOPERATION; NONHUMAN; PATENT; PRIORITY JOURNAL; PUBLIC HEALTH; VACCINE PRODUCTION;

DEVELOPING COUNTRIES; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; PUBLIC HEALTH; VACCINES;

EID: 67349201055     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2009.02.009     Document Type: Article

References (20)

1. Research and Markets. Global vaccine market outlook (2007-2010). http://www.researchandmarkets.com/reportinfo.asp?cat_id=0&report_id= 656467&q=Vaccine%20markets&p=1 [accessed 20.10.08]
2. Demain A.L. Small bugs, big business: the economic power of the microbe. Biotechnology Advances 18 6 (2000) 499-514
3. Clemens J., and Jodar L. Introducing new vaccines into developing countries: obstacles, opportunities and complexities. Nature Medicine 11 (2005) 12-15
4. A Chokshi D., and S Kesselheim A. Rethinking global access to vaccines. BMJ 336 (2008) 750-753
5. Richard T. Mahoney, James E. Maynard. The introduction of new vaccines into developing countries. Vaccine 17, 7-8, 646-652.
6. Jadhav S., Datla M., Kreeftenberg H., and Hendriks J. The developing vaccine manufacturer network is a critical constituency to ensure access to vaccines in developing countries. Vaccine 26 (2008) 1611-1615
7. Poeloengan T., Raw I., Martinez L.H., and El-Abbadi M. Developing Country Vaccine Manufacturers Network (DCVMN), April 26-27, 2001, Bandung, Indonesia. Vaccine 20 3-4 (2001) 285-287
8. Milstien J., Glass S., Batson A., Greco M., and Berger J. Divergence of vaccine product lines in industrialized and developing countries. Available at:. http://www.who.int/immunization_supply/divergence_vaccines.pdf [accessed 25.10.08]
9. Daout D. DCVMN presentation April 25 2007-DV.ppt. Available at:. www.who.int/entity/mediacentre/events/2007/avianinfluenza/dcvmn.pdfwww.w ho.int/entity/mediacentre/events/2007/avianinfluenza/dcvmn.pdf [accessed 25.10.08]
10. Developing Country Vaccine Manufacturers Network (DCVMN). Available from:. http://www.dcvmn.com/about-us/mission-vision.html [accessed on 21.10.08]
11. Fedson D.S. Vaccination for pandemic influenza and severe acute respiratory syndrome: common issues and concerns. Clinical Infectious Diseases 36 (2003) 1562-1563
12. Batson A. Sustainable introduction of affordable new vaccines: the targeting strategy. Vaccine 16 (1998) 93-98
13. Peny J.-M., Gleizes O., and Covilard J.-P. Financial requirements of immunization programmes in developing countries: a 2004-2014 perspective. Vaccine 23 (2005) 4610-4618
14. Grabowski H. Encouraging the development of new vaccines. Health Affairs 24 3 (2005) 697-700
15. Mahoney R.T., Pablos-Mendez A., and Ramachandran S. The introduction of new vaccines into developing countries. III. The role of intellectual property. Vaccine 22 5-6 (2004) 786-792
16. Jadhav S. Intellectual property rights and vaccines in developing countries. WHO workshop on Intellectual Property Rights. http://www.who.int/intellectualproperty/events/en/S.Jadhav.pdf
17. Morel C.M., Acharya T., Broun D., Dangi A., Elias C., Ganguly N.K., et al. Health innovation networks to help developing countries address neglected diseases. Science 309 (2005) 401-404
18. World Health Organization. Immediate and sustained action required to sharply increase pandemic influenza vaccine supply. Science Daily (2006, November 2). http://www.sciencedaily.com/releases/2006/10/061030122743.htm [accessed 23.10.08]
19. GAVI and developing countries. Details at website. http://www.gavialliance.org/about/in_partnership/developing/index.php
20. LaForce F.M., Konde K., Viviani S., and Préziosi M.P. The meningitis vaccine project. Vaccine 25 (2007) 97-100